EXACT Sciences Corp. Hits New 52-Week High at $103.92

EXACT Sciences Corp. has reached a significant milestone by hitting a new 52-week high of USD 103.92 on March 16, 2026. This achievement underscores the company's strong performance in the Pharmaceuticals & Biotechnology sector, where it operates as a mid-cap entity with a market capitalization of approximately USD 19.74 billion. Over the past year, EXACT Sciences Corp. has demonstrated impressive growth, with a remarkable 142.13% increase in stock price, significantly outperforming the S&P 500, which recorded an 18.81% gain during the same period. Despite being a loss-making entity, the company maintains a debt-to-equity ratio of 0.58, indicating a manageable level of debt relative to its equity. The stock's price-to-book ratio stands at 8.22, reflecting investor sentiment and the company's valuation in the market. With no dividend yield currently offered, investors are likely focused on capital appreciation as the primary return on investment. The previous 52-week low for the stock was recorded at USD 38.81, highlighting the substantial upward movement in its price.